Longeveron Corp (LGVN) - חוב לטווח קצר להון

The market value dynamics of Longeveron Inc. (LGVN) demonstrate a current metric of 0.06, which coincides with the expansion phase of the cellular treatment method for neonatal heart pathologies. The business relies on robotic cultivation systems that eliminate human error and contamination. Furthermore, Longeveron Inc. (LGVN) is developing scientific partnerships with medical centers to conduct in-depth research into combating aging through regenerative therapy.

For the biotechnology sector, where Longeveron Inc. conducts US law-protected developments in cell therapy, this indicator serves as a measure of short-term solvency. The ratio of liabilities maturing within one year to equity, reflecting the history of short-term borrowed capital relative to own funds, illustrates the business's reliance on express lending and confirms its resilience to external shocks in the absence of geopolitical risks.